Harmen Beurmanjer

156 Supplements People reporting at emergency departments with GHB overdose (Continued) Reference Aim Study design Methods Madah-Amiri et al., 2017 To examine characteristics and temporal trends of GHB/ GBL ambulance attended overdoses. Retrospective database between 2009-2015. N=1112 cases of GHB/GBL overdose patients attended by emergency and ambulance services in Bergen (Norway). Miro et al., 2002 To determine the number and percentage of GHB overdoses and to describe the clinical features and course of overdose. Retrospective database study between April 2000 – June 2001. N=104 presentations of GHB overdose at the emergency department of the University Hospital of Barcelona (Spain). Miro et al., 2017 To study the profile of European GHB and GBL intoxication and analyse differences in clinical features of GHB/GBL intoxication with and without co-abuse. Prospectively collected data between October 2013 to September 2014. N=710 GHB/GBL patients attended at the emergency department of 16 participating centres in the Euro-DEN network. Munir et al., 2008 To describe epidemiology, symptomatology, resource use and complications in patients presenting at the ED following GHB ingestion. Retrospective database study between 1-12-2002 to 31-5-2005. N=170 in 146 different individuals with GHB-related emergency attendances at St Vincent’s Hospital in Melbourne (Australia). Sporer et al., 2003 To describe the clinical features of patients with laboratory-confirmed GHB intoxication. Prospective case series from July 1998 through January 1999. N=16, patients with a clinical suspected GHB overdose at the emergency department of San Francisco General Hospital (United States). Van Sassenbroeck et al., 2007 To examine the time course of awakening from GHB intoxication, the relationship to GHB plasma concentrations and the presence of other drugs. Case series (2001-2003). N=15, unconscious (GCS≤8) participants who were treated at medical stations at six large rave parties in Belgium.